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Abstract 
The authors report the case of an 86-year-old man with a six-month history of chronic idiopathic urticaria, 
refractory to standard treatments. The patient did not report concomitant diseases and all clinical tests 
performed were normal. Laboratory tests showed only mild anemia and low serum iron (31 mcg/dl, 
normal value 59-158). After oral iron supplementation (105 mg/day of elemental iron, taken as ferrous 
sulphate) for two months, normal serum iron levels and complete remission of urticaria were observed. No 
further episodes of urticaria were reported at follow-up visits, six and twelve months later.  
The possible link between hyposideremia and urticaria is also discussed. In vitro experimental data 
suggest that transferrin inhibits histamine release from mast cells, and a direct correlation exists between 
the level of transferrin saturation and the degree of inhibition of histamine release. Reduced transferrin 
saturation due to hyposideremia could lower the threshold of stimulation required for mast cell 
degranulation, thus increasing the risk of urticaria in response to endogenous and/or exogenous pathogenic 
stimuli, even minimal. Further studies are necessary to better understand frequency and pathogenic 
mechanism(s) of “sideropenic urticaria” (chronic urticaria associated with hyposideremia and favourably 
responding to iron supplementation). From a clinical point of view, evaluation of serum iron levels in 
selected patients appears advisable, in the light of the relatively low cost and possible significant benefits 
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Introduction  
Chronic urticaria (CU) affects about 1% of the general population, and its clinical manifestations, 
particularly intense itch, can severely interfere with daily activities and/or sleep. Identification of 
cause(s) and treatment of CU can be challenging tasks for clinicians, because the etiopathogenic 
mechanisms of the disease are multiple and not yet completely clear, and antihistamines and/or 
corticosteroids are sometimes insufficient to induce complete remission [1]. 
 
Case report 
An 86-year-old man came to our observation with a six-month history of multiple erythematous-
purplish lesions, mainly located on the trunk (Figure 1). 
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These lesions were circular or arc
confluent, infiltrative and palpable, intensely 
itching, and were refractory to systemic therapy 
with antihistamines and corticosteroids.
Medical history of the patient was negative for 
significant diseases. Previous skin prick tests 
with aeroallergens and food allergens, patch 
tests with the standard series of haptens 
recommended by SIDAPA (Società Italiana di 
Dermatologia Allergologica, Professionale e
Ambientale – Italian Society for Allergological, 
Occupational and Environmental 
Dermatology), search for Helicobacter pylori
and  search  for  parasites  and  occult
three stool specimens had yielded negative results. Other laboratory tests, performed two weeks 
before our visit, are shown in Table 1 
iron level of 31 mcg/dl (normal value 59
Our clinical suspicion was confirmed by histopathological examination of a specimen of lesional 
skin, obtained by punch biopsy, which sh
inflammatory infiltrate of lymphocytes, neutrophils and rather numerous eosinophils around 
superficial and deep dermal vessels. 
Based on our previous clinical experience [1], oral iron supplementation (105 mg/day of 
elemental iron, taken as ferrous sulphate) for two months was suggested in addition to 
antihistamines.  
 
Table 1. Results of the blood tests performed (values out of no
Test (unit of measure) 
Red blood cells (number x106/L) 
Hemoglobin (g/dL) 
Hematocrit (%) 
MCV (fL) 
MHC (pg) 
MCHC (g/dL) 
RDW (%) 
White blood cells (number x103/L) 
Neutrophils (number x103/L) 
Lymphocytes (number x103/L) 
Monocytes (number x103/L) 
Eosinophils (number x103/L) 
Basophils (number x103/L) 
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  blood on  
Figure 1. Clinical picture of the patient: 
erythematous-purplish lesions, mainly located on the trunk.
and 2. Only signs of mild anemia were found, with a serum 
-158 mcg/dl). 
owed no significant epidermal alterations and 
 
rmal range are typed in boldface).
Value found 
4.04 
12.6 
38 
81.7 
26.8 
31.3 
14.5 
9.10 
7.29 
1.22 
0.53 
0.03 
0.03 
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Normal range 
4.50-5.90 
13-17 
39-50 
82-96 
27-32 
32-36 
11.5-15.5 
4-10 
1.80-7.50 
1.20-4 
0-0.80 
0-0.50 
0-15 
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Platelets (number x103/L) 200 140-400 
Erythrosedimentation rate (mm/hour) 9 1-15 
Total serum proteins (g/dL) 6.3 6.3-8.3 
Albumin (% of total serum proteins) 55.8 55.8-66.1 
Alpha 1 globulins (% of total serum proteins) 4.8 2.9-4.9 
Alfa 2 globulins (% of total serum proteins) 10.1 7.1-11.8 
Beta 1 globulins (% of total serum proteins) 5.5 4.7-7.2 
Beta 2 globulins (% of total serum proteins) 4.7 3.2-6.5 
Gamma globulins (% of total serum proteins) 17.8 11.1-18.8 
Albumin/globulin ratio 1.21 1.10-2.40 
IgA (g/L) 1.75 0.40-4 
IgG (g/L) 11.93 7-16 
IgM (g/L) 1.07 0.40-2.30 
PT ratio (%) 109 % 70-120 
INR 1 0.80-1.20 
aPTT (seconds) 28 22-35 
Fibrinogen (mg/dL) 355 150-450 
Glucose (mg/dL) 107 60-110 
Blood urea nitrogen (mg/dL) 34 10-50 
Serum creatinine (mg/dL) 1.01 0.60-1.20 
Uric acid (mg/dL) 5.7 3.5-7.2 
Triglycerides (mg/dL) 62 40-170 
Serum iron (g/dL) 31 59-158 
Transferrin (mg/dL) 301 200-400 
Ferritin (ng/mL) 21.6 18-370 
Na (mmol/L) 141 135-146 
K (mEq/L) 4.5 3.5-5.3 
AST (U/L) 22 0-42 
ALT (U/L) 24 0-50 
γGT (U/L) 26 0-50 
C3 (mg/dL) 142 82-185 
C4 (mg/dL) 35 15-53 
C1-INH (mg/dL) 28 15-35 
anti-streptolysin O (IU) 54 < 200 
C reactive protein (mg/dL) 0.13 0-0.50 
FT3 (pg/mL) 3.18 2.20-4.20 
FT4 (pmol/L) 12 9-16 
TSH (IU/mL) 2.334 0.300-4.200 
AbTg (IU/mL) 49 < 116 
AbTPO (IU/mL) 2 < 9 
 
 
After this period, the patient reported complete resolution of the cutaneous clinical picture, and 
serum iron levels were within the lower limits of normal (63 mcg/dl). As per our usual protocol 
[1], iron supplementation was suggested for another month, at the same daily dose. At follow-up 
visits after six and twelve months, progressive increase of serum iron (79 and 90 mcg/dl, 
respectively) was observed, and no relapses of urticaria were reported. 
 
Table 2. Results of urinalysis. 
Parameter (unit of measure) Value found Normal range 
pH 6.4 5-8 
specific gravity 1015 1001-1030 
glucose (mg/dL) 0 < 130 
proteins (mg/dL) 0 < 15 
urobilinogen (IU) 0 0.2-1 
red blood cells (number per high power field) 0 < 3 
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white blood cells (number per high power field) 0 < 6 
squamous epithelial cells (number per high power field) 5 < 20 
bilirubin, ketones, nitrites, casts, crystals, bacteria, yeasts not present not present 
 
Discussion 
The most recent data available [2] suggest that the prevalence of chronic idiopathic urticaria in 
the Italian population is about 0.38%, and 23.09% of patients are aged 65 years or more. Recent 
Italian data about hyposideremia are lacking, but this condition is usually reported as common in 
elderly subjects [3]. Despite this, surprisingly few studies exist on the association between 
hyposideremia and CU. The first paper on this topic, dating back to 1975, reported hyposideremia 
in 22 of 77 patients with CU, some of which had improvements or complete remission after iron 
supplementation [4]. Many years later, Sharma [5] published a case series of five patients with 
mild-to-moderate iron deficiency anemia and CU due to nickel sensitivity. In three of these 
patients, treatment with low nickel diet and 150 mg/day of iron led to remission of urticaria in 3 
to 4 weeks [5]. In 2014, we presented a study on 122 patients with chronic idiopathic urticaria 
(CIU) refractory to standard treatments [1]. Among those patients, about two thirds (n=81) had 
moderate hyposideremia. After adequate iron supplementation for 30 to 45 days, which led to 
restoration of normal serum iron levels, 64 of the above 81 reported complete remission of 
cutaneous manifestations and 17 an improvement superior to 80% in comparison to their basal 
disease severity score [1]. Association between hyposideremia and CIU, although with a lower 
frequency (16 of 188 patients), was then confirmed in another study [6]. The most recent version 
of the guidelines of the British Society for Allergy and Clinical Immunology for the management 
of chronic urticaria and angioedema reports that “if clinically indicated, measurement of serum 
iron and vitamin B12 levels can be useful” in the diagnostic workup of urticaria [7]. 
The new case presented here adds to the scarce number of reports in literature and confirms our 
previous results [1]. Another peculiarity of this case is the clinical resolution of urticaria with serum iron 
levels in the lower range of normal, an event observed in 3 of 15 similar cases in our previous 
experience [1] and not reported by other authors. 
The pathogenic mechanism which links hyposideremia to CIU is still unclear, also because this 
condition is the result of a complex interplay of multiple individual and environmental factors. Rather 
old but interesting studies [8-10] demonstrated that transferrin is able to inhibit histamine release from 
mast cells, and a direct correlation exists between the degree of transferrin saturation and the degree of 
inhibition of histamine release. Hyposideremia reduces transferrin saturation, thus possibly lowering the 
threshold of stimulation needed for mast cell degranulation and, consequently, urticaria [1]. However, 
hyposideremia is not always associated with urticaria, because the onset of clinical manifestations also 
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depends at least on the relative importance of the inhibitory effect of transferrin in mast cell 
homeostasis, the individual level of mast cell stability, and the type and magnitude of internal and/or 
external stimuli. 
Conclusions 
Further studies, on larger populations of different geographical and ethnic origin, appear desirable to 
better define frequency and importance of chronic urticaria associated with hyposideremia and 
favourably responding to iron supplementation (or, in our proposed definition, “sideropenic urticaria” 
[1]). Additionally, we believe that in vitro studies should be performed to understand the molecular 
mechanism(s) behind such association.  
From a clinical point of view, available data suggest that evaluation of serum iron levels can be 
considered in the diagnostic workup of chronic and apparently idiopathic urticaria in selected patients, 
in consideration of the relatively low cost and possible significant benefits. 
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